Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database

BACKGROUND: COVID-19 caused by SARS-CoV-2 virus emerged as an unprecedented challenge to discover effective drugs for its prevention and cure. Hyperinflammation-induced lung damage is one of the poor prognostic indicators causing a higher rate of morbidity and mortality of COVID-19 patients. Favipir...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Infect Drug Resist
Main Authors: Kaur, Rimple Jeet, Charan, Jaykaran, Dutta, Siddhartha, Sharma, Paras, Bhardwaj, Pankaj, Sharma, Praveen, Lugova, Halyna, Krishnapillai, Ambigga, Islam, Salequl, Haque, Mainul, Misra, Sanjeev
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751706/
https://ncbi.nlm.nih.gov/pubmed/33364790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S287934
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares